Aflac Incorporated (AFL)

Market Cap	55.43B
Revenue (ttm)	16.89B
Net Income (ttm)	3.59B
Shares Out	540.65M
EPS (ttm)	6.44
PE Ratio	15.91
Forward PE	14.98
Dividend	$2.32 (2.26%)
Ex-Dividend Date	May 21, 2025

Volume	1,641,325
Open	102.00
Previous Close	102.45
Day's Range	101.67 - 102.91
52-Week Range	86.46 - 115.50
Beta	0.83
Analysts	Hold
Price Target	104.64 (+2.06%)
Earnings Date	Apr 30, 2025

About AFL

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products t...

• Industry: Insurance - Life
• Sector: Financials
• Founded: 1955
• Employees: 12,694
• Stock Exchange: NYSE
• Ticker Symbol: AFL
• Website: https://www.aflac.com

Financial Performance

In 2024, Aflac's revenue was $18.93 billion, an increase of 1.21% compared to the previous year's $18.70 billion. Earnings were $5.44 billion, an increase of 16.83%.

Analyst Forecast

According to 14 analysts, the average rating for AFL stock is "Hold." The 12-month stock price forecast is $104.64, which is an increase of 2.06% from the latest price.

Price Target

$104.64

(2.06% upside)

Analyst Consensus: Hold